Marlan D. Walker - 03 Nov 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Reporting relationship: Chief Executive Officer
Issuer ticker: TXMD
Reported as of: 03 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Nov 2025, 16:16:56 UTC
Prior SEC filing: 15 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Marlan D. Walker

Key filing fact

Marlan D. Walker filed Form 4 for TherapeuticsMD, Inc. (TXMD) on 05 Nov 2025.

Key facts

This page summarizes Marlan D. Walker's Form 4 filing for TherapeuticsMD, Inc. (TXMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Nov 2025, 16:16.

Change

Previous filing in this sequence was filed on 15 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001820187 Primary reporting owner

Walker Marlan D

Relationship: Chief Executive Officer
Address: 951 YAMATO ROAD, SUITE 220, BOCA RATON
Signature: /s/ Marlan D. Walker
Signature date: 05 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TXMD transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +67,492
Change %
Price: $0.000000
Shares after: 67,492
Date: 03 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 67,492
Exercise price: $1.15
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Underlying shares each vested on November 3, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .